| Literature DB >> 32905814 |
Jia Liu1, Manasi K Mayekar2, Wei Wu2, Ming Yan3, Hongya Guan4, Jinwu Wang5, Aubhishek Zaman2, Yuanbo Cui4, Trever G Bivona2, Hani Choudhry6, Qinghe Xing7, Wei Cao8.
Abstract
The expression of lncRNA ESCCAL-1 is upregulated in esophageal squamous cell carcinoma (ESCC). However, the molecular pathways regulated by ESCCAL-1 in esophageal cancer remain obscure. We found that high expression of the lncRNA ESCCAL-1 in human ESCC tumors correlated with worse clinicopathologic features. Furthermore, depletion of ESCCAL-1 in ESCC models inhibited the cellular processes associated with malignancy, including proliferation, migration and invasion, resistance to apoptosis, and impaired tumor growth in mice. Using a combinatorial approach, we discovered that ESCCAL-1 regulates malignant phenotypes in ESCC by acting as a molecular sponge for miR-590-3p. This interaction prevents miR-590-3p from suppressing APOBEC3G expression. Increased APOBEC3G was also a biomarker of worse clinicopathologic features in human ESCC tumors. Depletion of ESSCAL-1 or APOBEC3G, or overexpression of miR-590-3p resulted in increased apoptosis due to downregulation of the PI3K/Akt signaling. This study demonstrates that the lncRNA ESCCAL-1 promotes malignant features of ESCC by relieving the inhibitory effect of miR-590-3p on APOBEC3G expression and identifies potential biomarkers or therapeutic targets to improve ESCC treatment outcomes.Entities:
Keywords: Esophageal squamous cell carcinoma; LncRNA; PI3K-Akt pathway; miR-590-3p
Mesh:
Substances:
Year: 2020 PMID: 32905814 DOI: 10.1016/j.canlet.2020.09.001
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679